Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Renger

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Annual Review of Pharmacology and Toxicology|November 19, 2016
The Discovery of Suvorexant, the First Orexin Receptor Drug for InsomniaPaul J Coleman, Anthony L Gotter, W Joseph Herring, et al.
Nature Nanotechnology|March 4, 2014
Three-dimensional manipulation with scanning near-field optical nanotweezersJ Berthelot, S S Aćimović, M L Juan, et al.
Neuropharmacology|April 12, 2012
Inhibition of T-type calcium current in rat thalamocortical neurons by isofluraneVeit-Simon Eckle, Michael R Digruccio, Victor N Uebele, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2002
Experience-dependent plasticity without long-term depression by type 2 metabotropic glutamate receptors in developing visual cortexJohn J Renger, Kenichi N Hartman, Yoshiko Tsuchimoto, et al.
Pharmacological Reviews|July 5, 2012
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacologyAnthony L Gotter, Andrea L Webber, Paul J Coleman, et al.
Sleep|November 29, 2007
Evaluation of automated and semi-automated scoring of polysomnographic recordings from a clinical trial using zolpidem in the treatment of insomniaVladimir Svetnik, Junshui Ma, Keith A Soper, et al.
Molecular Pharmacology|November 12, 2013
Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2Magali Cazade, Cindy E Nuss, Isabelle Bidaud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 8, 2012
GABAergic synaptic transmission triggers action potentials in thalamic reticular nucleus neuronsYan-Gang Sun, Chia-Shan Wu, John J Renger, et al.
Nature Neuroscience|March 22, 2000
Knocking the NT4 gene into the BDNF locus rescues BDNF deficient mice and reveals distinct NT4 and BDNF activitiesG Fan, C Egles, Y Sun, et al.
Progress in Brain Research|July 21, 2012
Orexin receptors as therapeutic drug targetsAnthony L Gotter, Anthony J Roecker, Richard Hargreaves, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Annual Review of Pharmacology and Toxicology|November 19, 2016
The Discovery of Suvorexant, the First Orexin Receptor Drug for InsomniaPaul J Coleman, Anthony L Gotter, W Joseph Herring, et al.
Nature Nanotechnology|March 4, 2014
Three-dimensional manipulation with scanning near-field optical nanotweezersJ Berthelot, S S Aćimović, M L Juan, et al.
Neuropharmacology|April 12, 2012
Inhibition of T-type calcium current in rat thalamocortical neurons by isofluraneVeit-Simon Eckle, Michael R Digruccio, Victor N Uebele, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2002
Experience-dependent plasticity without long-term depression by type 2 metabotropic glutamate receptors in developing visual cortexJohn J Renger, Kenichi N Hartman, Yoshiko Tsuchimoto, et al.
Pharmacological Reviews|July 5, 2012
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacologyAnthony L Gotter, Andrea L Webber, Paul J Coleman, et al.
Sleep|November 29, 2007
Evaluation of automated and semi-automated scoring of polysomnographic recordings from a clinical trial using zolpidem in the treatment of insomniaVladimir Svetnik, Junshui Ma, Keith A Soper, et al.
Molecular Pharmacology|November 12, 2013
Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2Magali Cazade, Cindy E Nuss, Isabelle Bidaud, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 8, 2012
GABAergic synaptic transmission triggers action potentials in thalamic reticular nucleus neuronsYan-Gang Sun, Chia-Shan Wu, John J Renger, et al.
Nature Neuroscience|March 22, 2000
Knocking the NT4 gene into the BDNF locus rescues BDNF deficient mice and reveals distinct NT4 and BDNF activitiesG Fan, C Egles, Y Sun, et al.
Progress in Brain Research|July 21, 2012
Orexin receptors as therapeutic drug targetsAnthony L Gotter, Anthony J Roecker, Richard Hargreaves, et al.
Pageof 13